Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient
- PMID: 20058580
Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient
Abstract
A 64-year old patient, who had bacteraemia, did not respond to vancomycin despite the MRSA isolate being sensitive to the antibiotic at MIC 2 microg/mL. Electron microscopy of the MRSA isolate showed thickening of the cell wall, which was not observed in MRSA with lower vancomycin MIC.
Similar articles
-
Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.J Antimicrob Chemother. 2011 Oct;66(10):2386-92. doi: 10.1093/jac/dkr301. Epub 2011 Jul 20. J Antimicrob Chemother. 2011. PMID: 21775337
-
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.Clin Infect Dis. 2008 Jan 15;46(2):193-200. doi: 10.1086/524667. Clin Infect Dis. 2008. PMID: 18171250
-
Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.J Antimicrob Chemother. 2010 May;65(5):1015-8. doi: 10.1093/jac/dkq050. Epub 2010 Mar 3. J Antimicrob Chemother. 2010. PMID: 20200036
-
Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.J Intensive Care Med. 2008 Sep-Oct;23(5):338-41. doi: 10.1177/0885066608320849. J Intensive Care Med. 2008. PMID: 18701528 Review.
-
Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).Int J Antimicrob Agents. 2013 Jun;42 Suppl:S17-21. doi: 10.1016/j.ijantimicag.2013.04.006. Epub 2013 May 8. Int J Antimicrob Agents. 2013. PMID: 23664580 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical